India Aims to Produce mRNA Covid-19 Vaccine This Year – The Wall Street Journal

NEW DELHIIndia is preparing to produce its ownmRNA-based Covid-19 vaccine by the end of the year, in what would be a scientific breakthrough for the countrys growing pharmaceutical industry and help expand the range of global production hubs for the shots.

A host of companies across the world are pushing to bring their own vaccines using themRNAtechnology to market following the success of the Pfizer Inc. and Moderna Inc. shots. Indian firms, urged on in part by Prime Minister Narendra Modi, aim to be significant players in the new sector, with Gennova Pharmaceuticals Ltd. hoping to be the first.

Read the original here:

India Aims to Produce mRNA Covid-19 Vaccine This Year - The Wall Street Journal

Related Posts
Tags: